Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis

NCT03265613 is registered in ClinicalTrials.gov with Guangdong Provincial Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT03265613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03265613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis
Lead sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Phase
Phase 1/2
Overall status
Completed
Start date
September 24, 2017
Completion date
November 28, 2019
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect, drug toxicity, mesenchymal stromal cells, psoriasis